Daniel Crona Lab

Daniel Crona’s highly collaborative translational research program is focused on a functional genomics paradigm that helps reveal molecular mechanisms that underlie the interplay between patient genotype, phenotype, and epigenetics. Molecular mechanistic information is then integrated with clinical pharmacology (e.g., pharmacokinetics and pharmacodynamics) to optimize drug selection and dosing. He has received funding from the UNC Eshelman Institute for Innovation, the NC TraCS Institute, the American College of Clinical Pharmacy, the Hematology Oncology Pharmacy Association, IBM, and Merck.